Dr. Marcello Rotta
Claim this profileColorado Blood Cancer Institute
Studies Acute Myeloid Leukemia
Studies Myeloid Leukemia
6 reported clinical trials
12 drugs studied
Area of expertise
1Acute Myeloid Leukemia
KMT2A positive
NPM1 positive
FLT3 positive
2Myeloid Leukemia
KMT2A positive
NPM1 positive
Affiliated Hospitals
Clinical Trials Marcello Rotta is currently running
SGR-2921
for Leukemia and Preleukemia
The purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) and/or recommended dose (RD) of SGR-2921.
Recruiting1 award Phase 1
Ziftomenib Combinations
for Acute Myeloid Leukemia
This Phase 1 study will assess the safety, tolerability, and preliminary antileukemic activity of ziftomenib in combination with venetoclax and azacitidine (ven/aza), ven, and 7+3 for two different molecularly-defined arms, NPM1-m and KMT2A-r.
Recruiting1 award Phase 1
More about Marcello Rotta
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Marcello Rotta has experience with
- Venetoclax
- Ziftomenib
- Azacitidine
- Daunorubicin
- Cytarabine
- Elotuzumab
Breakdown of trials Marcello Rotta has run
Acute Myeloid Leukemia
Myeloid Leukemia
Leukemia
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Marcello Rotta specialize in?
Marcello Rotta focuses on Acute Myeloid Leukemia and Myeloid Leukemia. In particular, much of their work with Acute Myeloid Leukemia has involved KMT2A positive patients, or patients who are NPM1 positive.
Is Marcello Rotta currently recruiting for clinical trials?
Yes, Marcello Rotta is currently recruiting for 3 clinical trials in Denver Colorado. If you're interested in participating, you should apply.
Are there any treatments that Marcello Rotta has studied deeply?
Yes, Marcello Rotta has studied treatments such as Venetoclax, Ziftomenib, Azacitidine.
What is the best way to schedule an appointment with Marcello Rotta?
Apply for one of the trials that Marcello Rotta is conducting.
What is the office address of Marcello Rotta?
The office of Marcello Rotta is located at: Colorado Blood Cancer Institute, Denver, Colorado 80218 United States. This is the address for their practice at the Colorado Blood Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.